InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (18 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
18
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Evans John M., Chairman & CEO. Director active across 1 company, notably Beam Therapeutics Inc.. Cumulatively, 35 filings have been published. Breakdown: 0 buy · 18 sells. Total volume traded: €10.6m. Activity tracked since 25 June 2021. The latest transaction was filed on 1 April 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Evans John M.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations35 total
18,663 sharesCommon StockSEC:0001193125-26-292526:0
6,337 sharesCommon StockSEC:0001193125-26-292526:1
13,421 sharesCommon StockSEC:0001193125-26-292526:2
11,579 sharesCommon StockSEC:0001193125-26-292526:3
25,000 sharesCommon StockSEC:0001193125-26-292526:4
23,100 sharesCommon StockSEC:0001193125-26-292526:5
1,900 sharesCommon StockSEC:0001193125-26-292526:6
30,078 shares@ US$24.586.5% of flowCommon StockSEC:0001193125-26-144086:0
90,000 shares0Common StockSEC:0001193125-26-138348:4
25,000 shares@ US$0.670.1% of flowCommon StockSEC:0001193125-26-138348:0
25,000 shares@ US$22.36924.5% of flowCommon StockSEC:0001193125-26-138348:1
25,000 shares@ US$0.670.1% of flowCommon StockSEC:0001193125-26-138348:2
25,000 shares@ US$22.76344.6% of flowCommon StockSEC:0001193125-26-138348:3
19,336 shares@ US$0.670.1% of flowCommon StockSEC:0001193125-26-033600:0
25,000 shares@ US$0.670.1% of flowCommon StockSEC:0001193125-25-230084:0
30,663 shares@ US$18.35065.7% of flowCommon StockSEC:0000950170-25-050857:0
30,000 shares@ US$0.670.2% of flowCommon StockSEC:0000950170-25-049297:0
77,500 shares0Common StockSEC:0000950170-25-049759:0
29,800 shares@ US$26.74598.3% of flowCommon StockSEC:0000950170-25-012304:0
60,000 shares@ US$24.600414.4% of flowCommon StockSEC:0000950170-24-111732:0
60,000 shares@ US$24.502614.9% of flowCommon StockSEC:0000950170-24-079065:0
18,102 shares@ US$32.135.9% of flowCommon StockSEC:0000950170-24-041432:0
60,000 shares@ US$33.856720.4% of flowCommon StockSEC:0000950170-24-039319:0
60,000 shares@ US$25.3315.2% of flowCommon StockSEC:0000950170-24-010477:0
5,161 shares@ US$30.311.6% of flowCommon StockSEC:0000899243-23-010819:0
25 of 35 declarations
About Evans John M.
Evans John M. is Président-Directeur Général at Beam Therapeutics Inc. (XNAS). He has 35 filings in total, and in the sampled recent filings they are sales for EUR 10589205 between 2021-06-30 and 2026-07-01.
